Locust Wood Capital Advisers LLC Has $113.17 Million Holdings in STERIS plc $STE

Locust Wood Capital Advisers LLC boosted its holdings in shares of STERIS plc (NYSE:STE) by 1.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 446,401 shares of the medical equipment provider’s stock after acquiring an additional 6,670 shares during the period. STERIS makes up approximately 2.7% of Locust Wood Capital Advisers LLC’s investment portfolio, making the stock its 17th largest holding. Locust Wood Capital Advisers LLC’s holdings in STERIS were worth $113,171,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Nordea Investment Management AB raised its holdings in STERIS by 259.0% during the 4th quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider’s stock worth $13,165,000 after buying an additional 37,228 shares during the period. Dimensional Fund Advisors LP increased its position in shares of STERIS by 9.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider’s stock worth $257,157,000 after acquiring an additional 89,250 shares in the last quarter. Legal & General Group Plc increased its position in shares of STERIS by 5.3% during the third quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider’s stock worth $171,505,000 after acquiring an additional 34,981 shares in the last quarter. Elo Mutual Pension Insurance Co acquired a new stake in shares of STERIS during the third quarter worth $2,480,000. Finally, Groupama Asset Managment bought a new stake in STERIS in the 3rd quarter valued at $1,163,000. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on STE shares. Wall Street Zen downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday. KeyCorp decreased their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Weiss Ratings lowered STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 27th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $270.00 price target on shares of STERIS in a research report on Thursday, May 21st. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $278.00.

STERIS Stock Performance

STE opened at $212.13 on Monday. The business’s 50-day simple moving average is $217.24 and its 200 day simple moving average is $238.96. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. The firm has a market capitalization of $20.70 billion, a PE ratio of 26.75 and a beta of 0.93.

STERIS (NYSE:STE) last posted its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, sell-side analysts expect that STERIS plc will post 11.18 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Monday, June 8th. STERIS’s dividend payout ratio is 31.78%.

Insider Transactions at STERIS

In other STERIS news, Director Richard C. Breeden sold 1,481 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $209.51, for a total value of $310,284.31. Following the completion of the sale, the director owned 38,964 shares in the company, valued at $8,163,347.64. This trade represents a 3.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.07% of the company’s stock.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.